Why Pharmacy Intelligence Will Be Pivotal in the New Healthcare Normal
As healthcare emerges from COVID-19, medication management and data intelligence will be pivotal as Pharmacy becomes a strategic driver for value-based decision making in health systems. In this recent roundtable discussion, leaders from EY-Parthenon and Omnicell shared important insights about how visibility and pharmacy analytics can lead to improved clinical, financial, and operational outcomes, including:
- Impact of medication management on the health system bottom line
- Pharmacy supply chain challenges uncovered by the pandemic and near- and long-term strategies for recovery and stabilization
- Leveraging pharmacy intelligence to create actionable benchmarks and drive insightful pharmacy management
Nhat H. Ngo
Executive Vice President, Marketing, Strategy & Business Development, Omnicell
Nhat has over 20 years of experience in global marketing, strategy, and business development in the healthcare sector. Nhat has deep expertise in predictive analytics, having led Omnicell’s intelligence solutions offering.
James Stevenson, PharmD
VP Medication Systems Strategy,
James has extensive experience in pharmacy and medication management, in both academic and health systems roles at major institutions including the University of Michigan, where he was Chief Pharmacy Officer for UM Health System.
Principal and Managing Director, EY-Parthenon, Ernst & Young LLP
Dan co-leads the firm’s Americas Healthcare team. His deep healthcare industry experience includes multi-site providers, academic medical centers, hospital services, healthcare technology, revenue cycle management, medical devices, and specialty pharmaceuticals.
Ernst & Young LLP
Dave specializes in growth strategy and M&A advisory services across a range of healthcare provider, service, and technology market segments. His expertise includes hospital and pharmacy services, physician practice management, behavioral health, and health information technology.